EMRNEUTRAL

EMR Revenue Growth (YoY) Analysis

7.0%

Updated 105h ago·SEC filings & market data

Key Takeaway

Revenue growth (YoY) measures the percentage change in sales compared to the same quarter last year; the current 2.9% means sales increased by just under 3% from the prior-year period.

Sector Performance

42th percentile

EMR

7.0%

Sector Median

9.0%

Sector Avg

14.8%

Prior Period

2.9%(Aug 2026)

↑ Improving
📊

Deep Analysis

Revenue growth (YoY) measures the percentage change in sales compared to the same quarter last year; the current 2.9% means sales increased by just under 3% from the prior-year period.

This is below the sector median of 7.9%, placing EMR in the 24th percentile among sector peers, so most peers are growing faster. The trend is not available because the year-over-year change and quarter-over-quarter change are both reported as N/A, and historical values only show the current 2.9% with no prior quarters. With a low level and no trend data, the investment risk is that the company is underperforming its sector in growth, but the lack of trend prevents judging whether this is improving or worsening. This metric contradicts the NEUTRAL verdict, as the sub-median growth and low percentile suggest a bearish signal on growth. However, the overall verdict remains neutral, meaning other factors likely offset this weak revenue growth.

Frequently Asked Questions

What does the Revenue Growth (YoY) tell investors about EMR?

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

How is the Revenue Growth (YoY) calculated?

Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.

Who are EMR's closest peers by Revenue Growth (YoY)?

The closest peers by Revenue Growth (YoY) include: TMUS (7.9%), MCK (7.7%), SIEGY (7.3%), CB (7.2%), MHK (6.8%).

The Formula

(Revenue_t - Revenue_t-4) / Revenue_t-4

Why It Matters

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

Advertisement

Master EMR's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full EMR research report

Free account — no credit card

EMR

7.0%

Sector Median

9.0%

Sector Avg

14.8%

How EMR's Revenue Growth (YoY) compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.